Sexual health after a breast cancer diagnosis in young women: clinical implications for patients and providers Sydney MarshVirginia F. BorgesAnosheh Afghahi Review 23 September 2020 Pages: 655 - 663
Treatment interruption and discontinuation of hormonal therapy in hormone receptor-positive breast cancer patients Daqin MaoHilal HachemSusan K. Parsons Review 12 September 2020 Pages: 665 - 674
Clinical practice to address tamoxifen nonadherence Richard R. LoveMichael BaumAndrea M. Straus Review 14 September 2020 Pages: 675 - 682
Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score Puneet SinghSarah E. TevisAnthony Lucci Preclinical study 04 September 2020 Pages: 683 - 687
Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer Yi ZhangJianfang LiuHai Hu Preclinical study 02 September 2020 Pages: 689 - 698
UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin Yanfang YangJing ZhaoZhansheng Jiang Preclinical study 10 September 2020 Pages: 699 - 710
Bone-protective and anti-tumor effect of baicalin in osteotropic breast cancer via induction of apoptosis Bangmin WangTao HuangHong Ge Preclinical study 16 September 2020 Pages: 711 - 721
Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study Anna BozziniLuca NicosiaMauro Giuseppe Mastropasqua Clinical trial Open access 28 August 2020 Pages: 723 - 731
Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience S. F. DentJ. BotrosL. E. Shepherd Clinical trial 17 September 2020 Pages: 733 - 741
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib Ji-Yeon KimKyunghee ParkYeon Hee Park Clinical trial 28 August 2020 Pages: 743 - 753
Impact of wait time from neoadjuvant chemotherapy to surgery in breast cancer: Does time to surgery affect patient outcomes? Valerie LaiOmar HajjajChristine Simmons Clinical trial 01 October 2020 Pages: 755 - 762
Screening women at high risk for breast cancer: one program fits all? Naama HermannAdi Klil-DroriTulin D. Cil Clinical trial 26 August 2020 Pages: 763 - 770
Diffuse tensor imaging of lower extremities: a novel MR imaging technique for chemotherapy-induced peripheral neuropathy Pavani ChalasaniMihra TaljanovicLana Gimber Clinical trial 28 August 2020 Pages: 771 - 778
Language impairment among patients with different types of cancer. Comparison with healthy adults Kalliopi Megari Clinical trial 27 August 2020 Pages: 779 - 782
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study E. MontagnaE. PaganV. Galimberti Clinical trial 14 September 2020 Pages: 783 - 795
Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy Chihwan ChaJanghee LeeJoon Jeong Clinical trial 09 September 2020 Pages: 797 - 803
Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer Max O. MeneveauJessica Keim-MalpassShayna L. Showalter Clinical trial 12 September 2020 Pages: 805 - 816
Utility of 70-kV single-energy CT in depicting the extent of breast cancer for preoperative planning Marehiko HisoshimaMisugi UranoYuta Shibamoto Clinical trial 10 September 2020 Pages: 817 - 823
Risk of primary urological and genital cancers following incident breast cancer: a Danish population-based cohort study Jens SundbøllDóra Körmendiné FarkasHenrik Toft Sørensen Epidemiology 26 August 2020 Pages: 825 - 837
The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients Dharmendra SinghAvik Mandal Epidemiology 27 August 2020 Pages: 839 - 848
Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer Naomi Y. KoMuhammad M. QureshiAriel E. Hirsch Epidemiology 04 September 2020 Pages: 849 - 859
A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection Sarah NietzDaniel S O’NeilHerbert Cubasch Epidemiology 01 September 2020 Pages: 861 - 872
Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia Kate R. PawloskiNicole ChristianAudree B. Tadros Epidemiology 28 August 2020 Pages: 873 - 880
Lobular neoplasia occult on conventional imaging and diagnosed on MRI-guided biopsy: can we estimate upgrade on surgical pathology? Yoav AmitaiTehillah S. MenesVivianne Freitas Epidemiology 04 September 2020 Pages: 881 - 890
Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark Elsebeth LyngeAnna-Belle BeauIlse Vejborg Epidemiology Open access 30 August 2020 Pages: 891 - 899
Pre-diagnostic allostatic load and health-related quality of life in a cohort of Black breast cancer survivors Cathleen Y. XingMichelle DooseAdana A. M. Llanos Epidemiology 10 September 2020 Pages: 901 - 914
Racial and ethnic disparities in 21-gene recurrence scores, chemotherapy, and survival among women with hormone receptor-positive, node-negative breast cancer Yunan HanZhi-Feng MiaoYing Liu Epidemiology 14 September 2020 Pages: 915 - 925
Prognostic associations of plasma hepcidin in women with early breast cancer Katarzyna J. JerzakAna E. LohmannPamela J. Goodwin Epidemiology 22 September 2020 Pages: 927 - 935
Factors associated with being diagnosed with high severity of breast cancer: a population-based study in Queensland, Australia Kou KouJessica CameronPeter D. Baade Epidemiology 14 September 2020 Pages: 937 - 950
The effect of breast MRI on disease-free and overall survival in breast cancer patients: a retrospective population-based study T. J. A. van NijnattenL. P. T. van TielM. B. I. Lobbes Epidemiology Open access 15 September 2020 Pages: 951 - 963
Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer Kimberley T. LeeLisa JacobsJodi B. Segal Epidemiology 10 September 2020 Pages: 965 - 975
Risk factors for implant failure following revision surgery in breast cancer patients with a previous immediate implant-based breast reconstruction A. FrisellJ. LagergrenJ. de Boniface Epidemiology Open access 12 September 2020 Pages: 977 - 984
Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes Frederik DemanKevin PunieGiuseppe Floris Epidemiology 12 September 2020 Pages: 985 - 998
Luminal subtypes and response to neoadjuvant chemotherapy for hormone receptor-positive HER2-negative patients Kadri Altundag Letter to the Editor 04 September 2020 Pages: 999 - 999
Letter to the editor with regard to the manuscript titled “Circulating tumour cell enumeration does not correlate with Miller–Payne grade in a cohort of breast cancer patients undergoing neoadjuvant chemotherapy” Rui ChenGe MaTiansong Xia Letter to the Editor 04 September 2020 Pages: 1001 - 1002